RIL
COLL icon

Rothschild Investment LLC’s Collegium Pharmaceutical COLL Stock Holding History

Rothschild Investment LLC’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.29K Buy
146
+59
+68% +$2.02K ﹤0.01% 2233
2026
Q1 		$2.88K Buy
87
+13
+18% +$550 ﹤0.01% 2362
2025
Q4 		$3.43K Buy
74
+14
+23% +$586 ﹤0.01% 2084
2025
Q3 		$2.1K Sell
60
-5
-8% -$174 ﹤0.01% 2205
2025
Q2 		$1.92K Buy
65
+20
+44% +$570 ﹤0.01% 2108
2025
Q1 		$1.34K Buy
45
+10
+29% +$306 ﹤0.01% 2156
2024
Q4 		$1K Buy
35
+15
+75% +$496 ﹤0.01% 2219
2024
Q3 		$773 Buy
20
+10
+100% +$357 ﹤0.01% 2329
2024
Q2 		$322 Buy
10
+5
+100% +$173 ﹤0.01% 2259
2024
Q1 		$194 Buy
+5
New +$175 ﹤0.01% 1752
2017
Q4 		– Sell
-16,910
Closed -$177K – 410
2017
Q3 		$177K Hold
16,910
– – 0.02% 391
2017
Q2 		$212K Buy
+16,910
New +$167K 0.02% 413

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Rothschild Investment LLC's COLL Position: Q2 2026 in Review

Rothschild Investment LLC increased its Collegium Pharmaceutical (COLL) stake by 68% in Q2 2026, buying an estimated $2.02K and bringing the position to 146 shares worth $5.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2233.

Rothschild Investment LLC first reported a position in COLL in Q2 2017 and has held it in 12 quarters since. The position peaked at $212K in Q2 2017. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Rothschild Investment LLC held 146 shares of Collegium Pharmaceutical worth $5.29K as of Q2 2026.
  • Rothschild Investment LLC bought 59 Collegium Pharmaceutical shares in Q2 2026, an estimated $2.02K.
  • Collegium Pharmaceutical made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2233 holding.
  • Rothschild Investment LLC first reported a position in Collegium Pharmaceutical in Q2 2017 and has held it in 12 quarters since.
  • Rothschild Investment LLC's Collegium Pharmaceutical position peaked at $212K in Q2 2017.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.